A detailed history of Covestor LTD transactions in Nuvalent, Inc. stock. As of the latest transaction made, Covestor LTD holds 122 shares of NUVL stock, worth $11,748. This represents 0.01% of its overall portfolio holdings.

Number of Shares
122
Previous 122 -0.0%
Holding current value
$11,748
Previous $9,000 44.44%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$72.35 - $88.99 $8,682 - $10,678
120 Added 6000.0%
122 $9,000
Q4 2023

Feb 09, 2024

SELL
$42.42 - $80.28 $42 - $80
-1 Reduced 33.33%
2 $0
Q3 2023

Nov 13, 2023

SELL
$39.12 - $49.85 $78 - $99
-2 Reduced 40.0%
3 $0
Q2 2023

Aug 11, 2023

SELL
$23.58 - $44.68 $23 - $44
-1 Reduced 16.67%
5 $0
Q4 2022

Feb 13, 2023

BUY
$18.46 - $36.37 $110 - $218
6 New
6 $0

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $4.14B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.